In June 2018, the U.S. FDA permitted marketing of two catheter-based devices designed to create dialysis AVF via percutaneous catheter-guided techniques. Devices function to avoid aspects of surgical complications: poor incisional site healing, Vessel clamping and dissection. Now, over five years since their first reports, percutaneous AVF is one of the most innovative and significant steps forward in native dialysis vascular access (VA) creation.
Upon completion of this course, attendees should be prepared to:
Describe the steps of the pAVF endovascular procedure
Identify the criteria for patient selection
Demonstrate the step-by-step duplex ultrasonography protocol used for the pre-operative vessel mapping and post-operative surveillance.
Release Date: 2/1/2022
Expiration Date: 1/31/2025
Estimated time to complete activity: 1 hour
Muhammad Hasan, RPVI
In accordance with the ACCME Standards for Commercial Support of CME, the speakers for this course have been asked to disclose to participants the existence of any financial interest and/or relationship(s) (e.g., paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation or whose products or services may be mentioned during their presentation. The following disclosures were made:
Planning Committee Members:
•Laurie Lozanski, BS RVS RVT, Course Director – No Relevant Relationships
•Susan Tyler, CME Director, Academic – No Relevant Relationships
•Bruce Gebhardt, MD – University of Cincinnati Reviewer – No Relevant Relationships
Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Accreditation Statement for Jointly Sponsored Activity
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Society for Vascular Ultrasound
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.